Product information and disease descriptionProduct descriptionProduct informationDrug/Drug, drug/disease interactions
Effects of Inaxaplin on other drugs
3 evidence topics · 2 sources
Sensitive CYP3A4 substrate: midazolam
“We assessed the potential of inaxaplin to either induce or inhibit CYP3A4 enzymes in Study 1 by measuring the effect of inaxaplin administration on serum concentrations of midazolam, a sensitive CYP3A4 substrate.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“There were no clinically significant PK drug-drug interactions between inaxaplin and midazolam (online Table S3).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Inaxaplin is not a clinically significant inhibitor or inducer of CYP3A4.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote